Exact Sciences (EXAS) Short Interest Ratio & Short Volume $47.76 +0.81 (+1.73%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$48.66 +0.91 (+1.89%) As of 08/1/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Exact Sciences Short Interest DataExact Sciences (EXAS) has a short interest of 7.47 million shares. This marks a 6.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 2.18 million shares to cover all short positions.Current Short Interest7,470,000 sharesPrevious Short Interest7,020,000 sharesChange Vs. Previous Month+6.41%Dollar Volume Sold Short$395.84 millionShort Interest Ratio2.6 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares188,640,000 sharesPercentage of Shares Shorted3.96%Today's Trading Volume2,486,655 sharesAverage Trading Volume2,176,708 sharesToday's Volume Vs. Average114% Short Selling Exact Sciences? Sign up to receive the latest short interest report for Exact Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEXAS Short Interest Over TimeEXAS Days to Cover Over TimeEXAS Percentage of Float Shorted Over Time Exact Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20257,470,000 shares $395.84 million +6.4%N/A2.6 $52.99 6/30/20257,020,000 shares $373.04 million -11.5%3.8%2.3 $53.14 6/15/20257,930,000 shares $424.41 million -25.7%4.3%2.8 $53.52 5/31/202510,670,000 shares $599.01 million -4.2%5.8%3.8 $56.14 5/15/202511,140,000 shares $625.73 million +10.1%6.1%4.3 $56.17 4/30/202510,120,000 shares $461.88 million -5.7%N/A4 $45.64 4/15/202510,730,000 shares $468.58 million -3.9%5.9%4.6 $43.67 3/31/202511,170,000 shares $483.55 million +5.4%6.1%4.6 $43.29 3/15/202510,600,000 shares $477 million -0.6%5.8%4.9 $45.00 2/28/202510,660,000 shares $505.39 million +4.4%5.8%4.9 $47.41 Get the Latest News and Ratings for EXAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exact Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202510,210,000 shares $503.46 million +2.8%5.6%4.7 $49.31 1/31/20259,930,000 shares $556.58 million -3.5%N/A3.9 $56.05 1/15/202510,290,000 shares $550.72 million -3.7%N/A4 $53.52 12/31/202410,690,000 shares $600.67 million -4.6%N/A4.6 $56.19 12/15/202411,200,000 shares $686 million -5.3%N/A4.7 $61.25 11/30/202411,830,000 shares $734.41 million -14.5%N/A4.4 $62.08 11/15/202413,840,000 shares $682.73 million -1.6%N/A5.1 $49.33 10/31/202414,060,000 shares $969.16 million -9.5%N/A5.9 $68.93 10/15/202415,540,000 shares $1.09 billion +10.8%N/A6.4 $69.95 9/30/202414,030,000 shares $955.72 million -14.6%N/A5.4 $68.12 9/15/202416,420,000 shares $1.08 billion +13.2%N/A5.9 $65.54 8/31/202414,510,000 shares $895.12 million +5.0%N/A5.3 $61.69 8/15/202413,820,000 shares $808.06 million +1.7%N/A4.8 $58.47 7/31/202413,590,000 shares $620.79 million -2.8%N/A4.1 $45.68 7/15/202413,980,000 shares $657.76 million -1.6%N/A4.7 $47.05 6/30/202414,210,000 shares $600.37 million +50.4%N/A4.7 $42.25 6/15/20249,450,000 shares $395.77 million +7.6%N/A3 $41.88 5/31/20248,780,000 shares $399.05 million +3.3%N/A3 $45.45 5/15/20248,500,000 shares $453.39 million -4.3%N/A2.9 $53.34 4/30/20248,880,000 shares $527.03 million -10.2%N/A3.6 $59.35 4/15/20249,890,000 shares $646.31 million +56.0%N/A4.1 $65.35 3/31/20246,340,000 shares $437.84 million -2.8%N/A2.8 $69.06 3/15/20246,520,000 shares $376.27 million -7.4%N/A3.4 $57.71 2/29/20247,040,000 shares $405.01 million -3.2%N/A3.6 $57.53 2/15/20247,270,000 shares $444.12 million -0.3%N/A4 $61.09 1/31/20247,290,000 shares $476.77 million -4.1%N/A4.3 $65.40 1/15/20247,600,000 shares $510.11 million +1.3%N/A4.6 $67.12 12/31/20237,500,000 shares $554.85 million +5.8%N/A4.5 $73.98 12/15/20237,090,000 shares $467.23 million -3.5%N/A4.4 $65.90 11/30/20237,350,000 shares $470.40 million +0.8%N/A5.1 $64.00This rock I’m holding could be worth trillions (Ad)A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.See the name and ticker behind America’s $16 trillion resource push. 11/15/20237,290,000 shares $460.14 million -3.7%N/A5.1 $63.12 10/31/20237,570,000 shares $466.24 million -7.3%N/A5.4 $61.59 10/15/20238,170,000 shares $533.26 million +7.8%N/A5.8 $65.27 9/30/20237,580,000 shares $517.11 million -11.7%N/A5.3 $68.22 9/15/20238,580,000 shares $657.91 million +0.4%N/A6.3 $76.68 8/31/20238,550,000 shares $715.38 million +1.9%N/A5.5 $83.67 8/15/20238,390,000 shares $721.71 million -2.9%N/A5.2 $86.02 7/31/20238,640,000 shares $842.75 million -4.4%N/A4.7 $97.54 7/15/20239,040,000 shares $875.70 million +1.8%N/A5.1 $96.87 6/30/20238,880,000 shares $833.83 million -13.0%N/A5 $93.90 6/15/202310,210,000 shares $953.51 million +8.9%N/A5.4 $93.39 5/31/20239,380,000 shares $765.22 million -4.4%N/A5 $81.58 5/15/20239,810,000 shares $793.92 million -11.7%N/A4.7 $80.93 4/30/202311,110,000 shares $711.82 million -3.2%N/A5.8 $64.07 4/15/202311,480,000 shares $766.75 million -2.7%N/A5.7 $66.79 3/31/202311,800,000 shares $800.16 million -4.7%N/A4.8 $67.81 3/15/202312,380,000 shares $796.78 million -5.3%N/A4.9 $64.36 2/28/202313,070,000 shares $814.65 million +18.2%N/A4.9 $62.33 2/15/202311,060,000 shares $731.51 million -7.0%N/A4.4 $66.14 1/31/202311,890,000 shares $802.81 million -7.5%N/A4.6 $67.52 1/15/202312,850,000 shares $886.14 million +11.8%N/A4.8 $68.96 12/30/202211,490,000 shares $568.87 million +15.1%N/A4.6 $49.51 12/15/20229,980,000 shares $445.21 million -1.4%N/A4.2 $44.61 11/30/202210,120,000 shares $454.89 million +2.0%N/A4.7 $44.95 11/15/20229,920,000 shares $439.26 million -2.6%N/A4.4 $44.28 10/31/202210,180,000 shares $354.06 million -4.1%N/A4.3 $34.78 10/15/202210,620,000 shares $322.32 million -9.2%N/A4.7 $30.35 9/30/202211,690,000 shares $379.81 million +4.2%N/A5.4 $32.49 9/15/202211,220,000 shares $458.79 million +14.0%N/A5.2 $40.89 8/31/20229,840,000 shares $349.81 million +4.5%N/A4.5 $35.55 8/15/20229,420,000 shares $416.74 million -2.9%N/A4.4 $44.24 7/31/20229,700,000 shares $437.47 million -9.7%N/A4.5 $45.10 7/15/202210,740,000 shares $503.71 million -3.1%N/A4.8 $46.90 6/30/202211,080,000 shares $436.44 million +1.3%N/A5 $39.39 6/15/202210,940,000 shares $423.27 million -5.2%N/A5 $38.69 5/31/202211,540,000 shares $574.81 million -14.6%N/A5.7 $49.81 5/15/202213,520,000 shares $706.96 million -0.5%N/A6.6 $52.29 4/30/202213,590,000 shares $748.13 million -4.2%N/A7.1 $55.05 4/15/202214,180,000 shares $987.07 million +3.1%N/A7.5 $69.61 3/31/202213,760,000 shares $962.10 million +1.8%N/A6.8 $69.92 3/15/202213,520,000 shares $778.21 million +5.0%N/A6.6 $57.56 2/28/202212,880,000 shares $1.01 billion +8.1%N/A6.2 $78.06 2/15/202211,920,000 shares $968.86 million -1.9%N/A5.6 $81.28 1/31/202212,150,000 shares $927.77 million +5.7%N/A6 $76.36 1/15/202211,500,000 shares $901.95 million +1.1%N/A5.7 $78.43 12/31/202111,370,000 shares $884.93 million -5.8%N/A6.6 $77.83 12/15/202112,070,000 shares $961.50 million -3.4%N/A7.5 $79.66 11/30/202112,500,000 shares $1.07 billion +4.2%N/A8.1 $85.37 11/15/202112,000,000 shares $1.08 billion +0.3%N/A8.3 $89.97 10/29/202111,960,000 shares $1.14 billion -6.2%N/A8.3 $95.22This rock I’m holding could be worth trillions (Ad)A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.See the name and ticker behind America’s $16 trillion resource push. 10/15/202112,750,000 shares $1.26 billion +19.4%N/A9.2 $98.96 9/30/202110,680,000 shares $1.02 billion -1.6%N/A7.7 $95.45 9/15/202110,850,000 shares $1.14 billion +9.5%N/A8.3 $104.65 8/31/20219,910,000 shares $1.03 billion +6.0%N/A7.6 $104.38 8/13/20219,350,000 shares $868.99 million +3.7%N/A7 $92.94 7/30/20219,020,000 shares $972.72 million +1.5%N/A6.3 $107.84 7/15/20218,890,000 shares $989.99 million -4.7%N/A6.4 $111.36 6/30/20219,330,000 shares $1.16 billion -0.2%N/A6.6 $124.31 6/15/20219,350,000 shares $1.15 billion -0.6%N/A6.4 $122.57 5/28/20219,410,000 shares $1.04 billion +1.3%N/A6.3 $110.53 5/14/20219,290,000 shares $870.10 million -2.1%N/A5.8 $93.66 4/30/20219,490,000 shares $1.26 billion -2.5%N/A5.9 $133.02 4/15/20219,730,000 shares $1.24 billion +1.7%N/A6 $127.14 3/31/20219,570,000 shares $1.18 billion +8.1%N/A5.3 $123.65 3/15/20218,850,000 shares $1.14 billion +4.1%N/A4.9 $128.46 2/26/20218,500,000 shares $1.12 billion +1.0%N/A4.6 $131.30 2/12/20218,420,000 shares $1.24 billion -1.1%N/A4.7 $146.68 1/29/20218,510,000 shares $1.19 billion -9.0%N/A5.2 $139.55 1/15/20219,350,000 shares $1.38 billion -4.2%N/A4.6 $147.29 12/31/20209,760,000 shares $1.32 billion -7.7%N/A5.2 $135.40 12/15/202010,570,000 shares $1.37 billion -2.0%N/A4.9 $129.80 11/30/202010,780,000 shares $1.27 billion -8.5%N/A5 $118.19 11/15/202011,780,000 shares $1.45 billion +1.7%N/A5.5 $122.71 10/30/202011,580,000 shares $1.40 billion -9.7%N/A5.5 $120.51 10/15/202012,830,000 shares $1.33 billion -6.1%N/A7.4 $103.50 9/30/202013,660,000 shares $1.39 billion +8.2%N/A7.8 $101.95 9/15/202012,630,000 shares $966.07 million -4.1%N/A7.8 $76.49 8/31/202013,170,000 shares $991.57 million No ChangeN/A9.3 $75.29 8/14/202013,170,000 shares $1.12 billion +2.3%N/A10.1 $85.33 EXAS Short Interest - Frequently Asked Questions What is Exact Sciences' current short interest? Short interest is the volume of Exact Sciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 7,470,000 shares of EXAS short. Learn More on Exact Sciences' current short interest. What is a good short interest ratio for Exact Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXAS shares currently have a short interest ratio of 3.0. Learn More on Exact Sciences's short interest ratio. Which institutional investors are shorting Exact Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exact Sciences: Twin Tree Management LP, Credit Industriel ET Commercial, Quaker Wealth Management LLC, Jane Street Group LLC, Millennium Management LLC, Caption Management LLC, Twin Tree Management LP, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Wolverine Asset Management LLC, Citigroup Inc., and Jefferies Financial Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Exact Sciences' short interest increasing or decreasing? Exact Sciences saw a increase in short interest in July. As of July 15th, there was short interest totaling 7,470,000 shares, an increase of 6.4% from the previous total of 7,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Exact Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biotechnology" compare to Exact Sciences: Biogen Inc. (2.67%), Incyte Corporation (3.73%), United Therapeutics Corporation (3.64%), Neurocrine Biosciences, Inc. (3.26%), Exelixis, Inc. (6.92%), BioMarin Pharmaceutical Inc. (3.19%), Halozyme Therapeutics, Inc. (7.88%), Repligen Corporation (6.40%), Ionis Pharmaceuticals, Inc. (8.30%), Madrigal Pharmaceuticals, Inc. (17.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Exact Sciences stock? Short selling EXAS is an investing strategy that aims to generate trading profit from Exact Sciences as its price is falling. EXAS shares are trading up $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exact Sciences? A short squeeze for Exact Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EXAS, which in turn drives the price of the stock up even further. How often is Exact Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXAS, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies BIIB Short Interest Data INCY Short Interest Data UTHR Short Interest Data NBIX Short Interest Data EXEL Short Interest Data BMRN Short Interest Data HALO Short Interest Data RGEN Short Interest Data IONS Short Interest Data MDGL Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXAS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
